Harvard

Backed by billionaires, a new biomedical institute tests an unorthodox approach
BioPharma Dive
Mon, 01/15/24 - 09:40 am
Arena BioWorks
Harvard
Stuart Schreiber
R&D
venture capital
Serial biotech founder Tim Springer on investing in startups and democratizing antibody research
BioPharma Dive
Fri, 05/26/23 - 09:47 am
Tim Springer
Harvard
biotech
R&D
Harvard spinout Surge emerges with $26M to make immunotherapy part of cancer surgery
MedCity News
Fri, 10/21/22 - 10:42 am
Surge Therapeutics
Harvard
immunotherapy
solid tumors
funding
Harvard spinout lands $40M to bring in vivo drug discovery to cancer
MedCity News
Fri, 07/15/22 - 11:02 am
Harvard
drug discovery
Manifold Bio
Cantex secures license to develop small molecule-drug for inflammatory lung diseases
Pharmaforum
Thu, 02/24/22 - 09:27 am
Cantex Pharmaceuticals
Harvard
small molecule drugs
azeliragon
Harvard spinout Nabla Bio lands $11M to bring AI technology to antibody design
MedCity News
Mon, 12/6/21 - 11:42 pm
Nabla Bio
Harvard
spinoffs
funding
antibody discovery
artificial intelligence
Synbio startup GRObio gets $25M to work with new building blocks for protein drugs
MedCity News
Wed, 11/3/21 - 11:31 pm
GRObio
Harvard
funding
Bayer
protein therapeutics
Novo Nordisk Foundation teams up with Broad Institute, Harvard for diabetes, obesity research hub
Fierce Biotech
Wed, 09/15/21 - 10:54 am
Novo Nordisk Foundation
Broad Institute
Harvard
diabetes
obesity
R&D
Harvard stem cell research lead Jonathan Hoggatt joins Moderna as director of hematology
Fierce Biotech
Fri, 03/5/21 - 10:14 am
Moderna Therapeutics
stem cells
Harvard
AbbVie Taps Harvard University for Viral Infection Research Partnership
BioSpace
Wed, 08/26/20 - 10:53 am
AbbVie
Harvard
R&D
viral infections
coronaviruses
hemorrhagic fever
Lung cancer study IDs new 'epigenomic' target for diagnosis and treatment
Fierce Biotech
Fri, 07/24/20 - 09:32 am
Harvard
MIT
epigenomics
cancer
lung cancer
diagnostics
Bayer helps Harvard spinout Vesigen to $28.5M series A
Fierce Biotech
Wed, 07/22/20 - 10:39 am
Bayer
Vesigen Therapeutics
Harvard
RNAi
MRNA
CRISPR
Biogen boosts gene therapy strategy with Harvard pact focused on inherited eye disease
Fierce Biotech
Mon, 07/6/20 - 12:00 pm
Biogen
gene therapy
eye disease
Harvard
Say What? A Printable Antibody Test for the COVID-19 Virus?
Medical Devices and Diagnostics Industry
Fri, 06/12/20 - 08:05 pm
iQ Group Global
Harvard
COVID-19
antibody tests
diagnostics
Harvard animal studies suggest COVID-19 protection can come from previous infection or DNA vaccine
Fierce Biotech
Thu, 05/21/20 - 10:35 am
COVID-19
pandemic
coronavirus
Harvard
antibodies
vaccines
Harvard pens Astellas research deal, vowing to push on despite pandemic
Fierce Biotech
Tue, 04/28/20 - 11:48 pm
Harvard
Astellas
R&D
COVID-19
Harvard professors call on FDA to maintain review standards amid COVID-19
RAPS.org
Wed, 04/15/20 - 11:34 pm
Harvard
New England Journal of Medicine
FDA
drug approvals
COVID-19
pandemic
With Harvard Tech and $5M, PIC Therapeutics Takes Aim at Cancer
Xconomy
Wed, 04/15/20 - 10:38 am
PIC Therapeutics
Harvard
cancer
oncology
Harvard joins coronavirus fight with $115M and a high-profile Chinese partner
Endpoints
Tue, 02/25/20 - 10:17 am
Harvard
China
Guangzhou Institute
COVID-19
Vizgen Launches With $14M to Market New Subcellular Imaging Technique
Xconomy
Thu, 01/30/20 - 10:50 am
imaging
devices
Vizgen
subcellular imaging
Harvard

Pages